Lakeshore Biopharma Co Stock Probability of Future Stock Price Finishing Over 0.26
| LSBCF Stock | 0.26 0.14 35.00% |
LakeShore | Build AI portfolio with LakeShore Stock |
LakeShore Biopharma Target Price Odds to finish over 0.26
The tendency of LakeShore Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.26 | 90 days | 0.26 | close to 99 |
Based on a normal probability distribution, the odds of LakeShore Biopharma to move above the current price in 90 days from now is close to 99 (This LakeShore Biopharma Co probability density function shows the probability of LakeShore Stock to fall within a particular range of prices over 90 days) .
LakeShore Biopharma Price Density |
| Price |
Predictive Modules for LakeShore Biopharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as LakeShore Biopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of LakeShore Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
LakeShore Biopharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. LakeShore Biopharma is not an exception. The market had few large corrections towards the LakeShore Biopharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold LakeShore Biopharma Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of LakeShore Biopharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.85 | |
β | Beta against Dow Jones | -2.82 | |
σ | Overall volatility | 0.09 | |
Ir | Information ratio | -0.15 |
LakeShore Biopharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of LakeShore Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for LakeShore Biopharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| LakeShore Biopharma generated a negative expected return over the last 90 days | |
| LakeShore Biopharma has high historical volatility and very poor performance | |
| LakeShore Biopharma has some characteristics of a very speculative penny stock | |
| LakeShore Biopharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 614.96 M. Net Loss for the year was (99.98 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| LakeShore Biopharma generates negative cash flow from operations | |
| LakeShore Biopharma has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Buyer group questions LakeShore Biopharma take-private after RMB576.5m liability - stocktitan.net |
LakeShore Biopharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of LakeShore Stock often depends not only on the future outlook of the current and potential LakeShore Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. LakeShore Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 106.9 M | |
| Cash And Short Term Investments | 28.1 M |
LakeShore Biopharma Technical Analysis
LakeShore Biopharma's future price can be derived by breaking down and analyzing its technical indicators over time. LakeShore Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of LakeShore Biopharma Co. In general, you should focus on analyzing LakeShore Stock price patterns and their correlations with different microeconomic environments and drivers.
LakeShore Biopharma Predictive Forecast Models
LakeShore Biopharma's time-series forecasting models is one of many LakeShore Biopharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary LakeShore Biopharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about LakeShore Biopharma
Checking the ongoing alerts about LakeShore Biopharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for LakeShore Biopharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| LakeShore Biopharma generated a negative expected return over the last 90 days | |
| LakeShore Biopharma has high historical volatility and very poor performance | |
| LakeShore Biopharma has some characteristics of a very speculative penny stock | |
| LakeShore Biopharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 614.96 M. Net Loss for the year was (99.98 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| LakeShore Biopharma generates negative cash flow from operations | |
| LakeShore Biopharma has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Buyer group questions LakeShore Biopharma take-private after RMB576.5m liability - stocktitan.net |
Check out LakeShore Biopharma Analysis, LakeShore Biopharma Valuation, LakeShore Biopharma Correlation, LakeShore Biopharma Hype Analysis, LakeShore Biopharma Volatility, LakeShore Biopharma Price History as well as LakeShore Biopharma Performance. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Can Biotechnology industry sustain growth momentum? Does LakeShore have expansion opportunities? Factors like these will boost the valuation of LakeShore Biopharma. Expected growth trajectory for LakeShore significantly influences the price investors are willing to assign. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating LakeShore Biopharma demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Understanding LakeShore Biopharma requires distinguishing between market price and book value, where the latter reflects LakeShore's accounting equity. The concept of intrinsic value - what LakeShore Biopharma's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Market sentiment, economic cycles, and investor behavior can push LakeShore Biopharma's price substantially above or below its fundamental value.
Understanding that LakeShore Biopharma's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether LakeShore Biopharma represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, LakeShore Biopharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.